BBC News and Press, Virtus LifeSci Biotech Clinical Trials From 07/02/25

2025-07-02 04:50:00 ET A Bumpy Road Higher The path of least resistance entering the second half of the year would be to say risk-on, with equity markets trending higher from here. But we can’t forget a timeless piece of strategic wisdom: “Hope is not a strategy.ȁ...

2025-06-13 14:32:00 ET By Christian Floro, CFA, CMT, Market Strategist and Kiara Cao, Analyst, Multi-Asset Research ... Read the full article on Seeking Alpha For further details see: Who Will Benefit From Deregulation?

2025-06-04 04:45:00 ET Summary As we approach the midpoint of 2025, volatility is defining the investment landscape. The Trump administration in the U.S. has gone in hard on trade tariffs, disrupting previous relationships and structures. Market volatility has surged this year...

2025-06-02 06:30:00 ET Summary Looking at Q1 ’25 earnings trends, the healthcare sector reported a solid quarter, even with UnitedHealth’s issues. Q2 and Q3 ’25 are showing lower or negative revisions, and lower levels of absolute healthcare EPS growth. It...

2025-05-31 01:50:00 ET Summary Q1 company earnings painted a picture of corporate health as markets entered a period of trade tumult. Fundamental Equities CIO Carrie King discusses the importance of staying invested amid volatility, and outlines where there may be opportunities fo...

2025-05-30 15:30:00 ET Summary Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers. How investors should consider positioning themselves as uncertainty hits healthcare sector. The U.S. is proposing major policy changes ...

2025-05-20 04:00:00 ET Summary The current administration’s economic policies — particularly on trade — appear to be worsening the growth/inflation trade-off. I expect to start seeing the impact of tariffs between late May and early July. If you’re ...

2025-05-19 20:45:00 ET Summary Contrary to what the buoyant stock market might be indicating, this combination of trade policy uncertainty and unusually high import tariff levels does not bode well for this year’s US economic outlook. The only trade agreement that has been ...

2025-05-12 22:35:00 ET Summary Last Thursday, President Trump said “buy.” Investors saluted, clicked, and positioned for a trade breakthrough. On Monday, they got one. Stocks exploded Monday on word that US-China tariffs will fall sharply for at least 90 days. Th...

2025-05-12 09:07:07 ET Summary Investors who've been looking for problems at Intellia Therapeutics have, during the past year, had an easy time finding them. A tendency to misinterpret helped. Investors complained about test results that were fine with medical experts and the FDA....